Atlas Trials

Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)

Clinical trial NCT03403686 · RECRUITING

Trial details

NCT number
NCT03403686
Sponsor
University of Alabama at Birmingham
Status
RECRUITING
Study type
OBSERVATIONAL
Diabetic Retinopathy
Start date
2018-01-11
Primary completion
2026-12-31
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.